Industry & Mining · Pharmaceutical active pharmaceutical ingredients (APIs) production

Pharmaceutical active pharmaceutical ingredients (APIs) production in Norway in 2026

Norway produces no active pharmaceutical ingredients: in 2026, the volume was 0 tonnes, placing the country 33rd out of 197 nations. Despite a well-developed pharmaceutical sector (companies like Nycomed and GE Healthcare), the country focuses on R&D and finished dosage forms, while API synthesis remains in China and India due to Norway's high environmental standards and production costs.

Data for 2026 · unit: tonnes
Position

Norway world ranking

#33 / 197

Country position on the scale from last to first place for this indicator.

NO
#33
#197#1
Trend

Change over time

Change in indicator over the available period.

5
1950
70
1990
90
2000
0
2010
0
2020
0
2025
0
2026

Values — tonnes

Comparison

Top countries by Pharmaceutical active pharmaceutical ingredients (APIs) production

Where Norway stands in the world ranking.

Full world rankingarrow_forward
Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical active pharmaceutical ingredients (APIs) production in Norway — how much?
Based on 2026 data — 0 tonnes. This is rank #33 out of 197 countries.
What is Norway's rank by Pharmaceutical active pharmaceutical ingredients (APIs) production?
Norway ranks #33 out of 197 countries in the world ranking by «Pharmaceutical active pharmaceutical ingredients (APIs) production».
How has Pharmaceutical active pharmaceutical ingredients (APIs) production changed in Norway?
Over the available period the indicator changed from 5 to 0 tonnes.